Drugmaker CEOs are skeptical that artificial intelligence will revolutionize medicine, citing that no AI-designed drug has yet received FDA approval. They believe biological complexity remains a significant hurdle. Separately, new guidance has been issued for expert witnesses regarding the use of artificial intelligence in legal proceedings. AI
IMPACT Questions arise about AI's practical impact in drug discovery, while new guidelines address its use in legal contexts.
RANK_REASON The cluster contains opinion pieces and guidance documents related to AI, rather than a direct release or significant industry event.
Read on Mastodon — sigmoid.social →
AI-generated summary · Google Gemini · from 3 sources. How we write summaries →